NMRA · Neumora Therapeutics, Inc. · Fails to Deliver
$0.33
-0.01 (-3.78%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q4 2025 earnings call transcript
Going-concern doubt
— flagged Nov 16, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, the Company has concluded that substantial doubt exists about its ability to continue as a going concern.”View the 10-Q filed Nov 16, 2026
Market Cap
$63.01M
Shares
188.69M
Volume · Nov 20
1.06M
Avg daily vol (3M)
1.67M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Key facts
CIK
1885522
CUSIP
640979100
13F (30d)
143 filings
117 filers
Visit website
Investor relations